The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Novel “anti-reverse” cap analogs with superior translational properties
Open accessAbstract
Synthetic analogs of the 5′-terminal caps of eukaryotic mRNAs and snRNAs are used in elucidating such physiological processes as mRNA translation, pre-mRNA splicing, intracellular transport of mRNA and snRNAs, and mRNA turnover. Particularly useful are RNAs capped with synthetic analogs, which are produced by in vitro transcription of a DNA template using a bacteriophage RNA polymerase in the presence of ribonucleoside triphosphates and a cap dinucleotide such as m 7 Gp 3 G. Unfortunately, because of the presence of a 3′-OH on both the m 7 Guo and Guo moieties, up to half of the mRNAs contain caps incorporated in the reverse orientation. Previously we designed and synthesized two “anti-reverse” cap analogs (ARCAs), m 7 3′dGp 3 G and m 27,3′-O Gp 3 G, that cannot be incorporated in the reverse orientation because of modifications at the C3′ position of m 7 Guo. In the present study, we have synthesized seven new cap analogs modified in the C2′ and C3′ positions of m 7 Guo and in the number of phosphate residues, m 27,2′-O Gp 3 G, m 7 2′dGp 3 G, m 7 2′dGp 4 G, m 27,2′-O Gp 4 G, m 27,3′-O Gp 4 G, m 7 Gp 5 G, and m 27,3′-O Gp 5 G. These were analyzed for conformation in solution, binding affinity to eIF4E, inhibition of in vitro translation, degree of reverse capping during in vitro transcription, capping efficiency, and the ability to stimulate cap-dependent translation in vitro when incorporated into mRNA. The results indicate that modifications at C2′, like those at C3′, prevent reverse incorporation, that tetra- and pentaphosphate cap analogs bind eIF4E and inhibit translation more strongly than their triphosphate counterparts, and that tetraphosphate ARCAs promote cap-dependent translation more effectively than previous cap analogs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121
The relationship between proton-proton NMR coupling constants and substituent electronegativities—I
Haasnoot, C. A. G., de Leeuw, F. A. A. M., & Altona, C. (1980) · Tetrahedron · doi:10.1016/0040-4020(80)80155-4 · Cited by 2,035
Translational control of gene expression
Sonenberg, N., Hershey, J. W. B., & Mathews, M. B. (2000) · Cold Spring Harbor Laboratory eBooks · Cited by 1,379
Cocrystal Structure of the Messenger RNA 5′ Cap-Binding Protein (eIF4E) Bound to 7-methyl-GDP
Marcotrigiano, J., Gingras, A.-C., Sonenberg, N., & Burley, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80280-9 · Cited by 678
Forces contributing to the conformational stability of proteins
Pace, C. N., Shirley, B. A., McNutt, M., & Gajiwala, K. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.1.8566551 · Cited by 650
Recognition of cap structure in splicing in vitro of mRNA precursors
Konarska, M. M., Padgett, R. A., & Sharp, P. A. (1984) · Cell · doi:10.1016/0092-8674(84)90268-x · Cited by 568
A nuclear cap binding protein complex involved in pre-mRNA splicing
Izaurralde, E., Lewis, J., McGuigan, C., Jankowska, M., Darzynkiewicz, E., & Mattaj, I. W. (1994) · Cell · doi:10.1016/0092-8674(94)90530-4 · Cited by 517
Self-citationViral and cellular mRNA capping: Past and prospects
Furuichi, Y., & Shatkin, A. J. (2000) · Advances in Virus Research · doi:10.1016/s0065-3527(00)55003-9 · Cited by 404
Niedzwiecka, A., Marcotrigiano, J., Stepinski, J., Jankowska-Anyszka, M., Wyslouch-Cieszynska, A., Dadlez, M., Gingras, A.-C., Mak, P., Darzynkiewicz, E., Sonenberg, N., et al. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00328-5 · Cited by 380
Self-citationStructure of translation factor elF4E bound to m7GDP and interaction with 4E-binding protein
Matsuo, H., Li, H., McGuire, A. M., Fletcher, C. M., Gingras, A.-C., Sonenberg, N., & Wagner, G. (1997) · Nature Structural Biology · doi:10.1038/nsb0997-717 · Cited by 377
Cap trimethylation of U snRNA is cytoplasmic and dependent on U snRNP protein binding
Mattaj, I. W. (1986) · Cell · doi:10.1016/0092-8674(86)90072-3 · Cited by 377
(2001) · PubMed Central · Cited by 342
An essential component of the decapping enzyme required for normal rates of mRNA turnover
Beelman, C. A., Stevens, A., Caponigro, G., LaGrandeur, T. E., Hatfield, L., Fortner, D. M., & Parker, R. (1996) · Nature · doi:10.1038/382642a0 · Cited by 327
Hamm, J., Darzynkiewicz, E., Tahara, S. M., & Mattaj, I. W. (1990) · Cell · doi:10.1016/0092-8674(90)90021-6 · Cited by 298
Self-citationChappell, J. D. (2002) · The EMBO Journal · doi:10.1093/emboj/21.1.1 · Cited by 278
eIF4G Dramatically Enhances the Binding of eIF4E to the mRNA 5′-Cap Structure
Haghighat, A., & Sonenberg, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21677 · Cited by 239
Andreopoulos, A. G., Hatzi, E., & Doxastakis, M. (1999) · Journal of Materials Science: Materials in Medicine · doi:10.1023/a:1008887910068 · Cited by 229
Lankhorst, P. P., Haasnoot, C. A. G., Erkelens, C., & Altona, C. (1984) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.1984.10507527 · Cited by 221
Signal Transduction Pathways That Regulate Eukaryotic Protein Synthesis
Rhoads, R. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30337 · Cited by 201
Self-citationStructural basis of m7GpppG binding to the nuclear cap-binding protein complex
Calero, G., Wilson, K. F., Ly, T., Rios-Steiner, J. L., Clardy, J. C., & Cerione, R. A. (2002) · Nature Structural Biology · doi:10.1038/nsb874 · Cited by 169
[4] Synthesis of long, capped transcripts in Vitro by SP6 and T7 RNA polymerases
Yisraeli, J. K., & Melton, D. A. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(89)80090-4 · Cited by 166
Zuberek, J., Wysłouch‐Cieszyńska, A., Niedźwiecka-Kornaś, A., Dadlez, M., Stȩpiński, J., Augustyniak, W., Gingras, A., ZHANG, Z., Burley, S. K., Sonenberg, N., et al. (2003) · RNA · doi:10.1261/rna.2133403 · Cited by 161
Self-citationContreras, R., Cheroutre, H., Degrave, W., & Fiers, W. (1982) · Nucleic Acids Research · doi:10.1093/nar/10.20.6353 · Cited by 154
A cap binding protein that may mediate nuclear export of RNA polymerase II-transcribed RNAs.
Izaurralde, E., Stȩpiński, J., Darżynkiewicz, E., & Mattaj, I. W. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.6.1287 · Cited by 153
Fischer, U., Darżynkiewicz, E., Tahara, S. M., et al. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.113.4.705 · Cited by 148
Reverse 5' caps in RNAs made in vitro by phage RNA polymerases.
Pasquinelli, A. E., Dahlberg, J. E., & Lund, E. (1995) · PubMed · Cited by 147
Functional Characterization of Five eIF4E Isoforms inCaenorhabditis elegans
Keiper, B. D., Lamphear, B. J., Deshpande, A. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10590 · Cited by 147
Tomoo, K., Shen, X., Okabe, K., Nozoe, Y., Fukuhara, S., Morino, S., Ishida, T., Taniguchi, T., Hasegawa, H., Terashima, A., et al. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620539 · Cited by 139
Hendler, S. S., Fuerer, E., & Srinivasan, P. (1970) · Biochemistry · doi:10.1021/bi00823a017 · Cited by 135
Wei, C., Balasta, M. L., Ren, J., & Goss, D. J. (1998) · Biochemistry · doi:10.1021/bi9724570 · Cited by 135
Quantitative Assessment of mRNA Cap Analogues as Inhibitors of in Vitro Translation
Cai, A., Jankowska‐Anyszka, M., Centers, A., Chlebicka, L., Stȩpiński, J., Stolarski, R., Darżynkiewicz, E., & Rhoads, R. E. (1999) · Biochemistry · doi:10.1021/bi9830213 · Cited by 123
Self-citationFortes, P., Inada, T., Preiß, T., Hentze, M. W., Mattaj, I. W., & Sachs, A. B. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00003-1 · Cited by 107
-globin mRNAs capped with m7G, m22.7G or m32.2.7G differ in intrinsic translation efficiency
Darżynkiewicz, E., Stȩpiński, J., Ekiel, I. H., Jin, Y., Haber, D., Sijuwade, T., & Tahara, S. M. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.18.8953 · Cited by 89
Edery, I., Altmann, M., & Sonenberg, N. (1988) · Gene · doi:10.1016/0378-1119(88)90184-9 · Cited by 87
Synthesis and Application of a Chain-Terminating Dinucleotide mRNA Cap Analog
Peng, Z., Sharma, V., Singleton, S. F., & Gershon, P. D. (2001) · Organic Letters · doi:10.1021/ol0167715 · Cited by 80
Chemical synthesis and characterization of 7-methylguanosine cap analogs
Darżynkiewicz, E., Ekiel, I. H., Tahara, S. M., Seliger, L. S., & Shatkin, A. J. (1985) · Biochemistry · doi:10.1021/bi00328a020 · Cited by 71
Darżynkiewicz, E., Stȩpiński, J., Ekiel, I. H., Goyer, C., Sonenberg, N., Temeriusz, A., Jin, Y., Sijuwade, T., Haber, D., & Tahara, S. M. (1989) · Biochemistry · doi:10.1021/bi00437a038 · Cited by 53
Darżynkiewicz, E., Stȩpiński, J., Tahara, S. M., Stolarski, R., Ekiel, I. H., Haber, D., Neuvonen, K., Lehikoinen, P., Labádi, I., & Lönnberg, H. (1990) · Nucleosides and Nucleotides · doi:10.1080/07328319008045191 · Cited by 48
Self-citationSteogon, J., Bretner, M., Jankowska, M., Felczak, K., Stolarski, R., Wieczorek, Z., Caipostalcode, A.-L., Rhoads, R. E., Temeriusz, A., Haber, D., et al. (1995) · Nucleosides and Nucleotides · doi:10.1080/15257779508012457 · Cited by 48
Self-citationDarżynkiewicz, E., Ekiel, I. H., Lassota, P., & Tahara, S. M. (1987) · Biochemistry · doi:10.1021/bi00388a028 · Cited by 46
14 Heme-regulated eIF2α KinasePreprint
Chen, J.-J. (2000) · Cold Spring Harbor Monograph Archive · doi:10.1101/087969618.39.529 · Cited by 40
Carberry, S. E., Friedland, D. E., Rhoads, R. E., & Goss, D. J. (1992) · Biochemistry · doi:10.1021/bi00120a020 · Cited by 38
Self-citationThe Cap Structure of Eukaryotic Messenger RNA and its Interaction with Cap-binding Protein
Rhoads, R. E. (1985) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-70203-7_3 · Cited by 32
Self-citationEfficient Synthesis of 13C,15N-Labeled RNA Containing the Cap Structure m7GpppA
Matsuo, H., Moriguchi, T., Takagi, T., Kusakabe, T., Buratowski, S., Sekine, M., Kyogoku, Y., & Wagner, G. (2000) · Journal of the American Chemical Society · doi:10.1021/ja9926820 · Cited by 21
Fluorescence and NMR studies of intramolecular stacking of mRNA cap-analogues
Wieczorek, Z. J., Zdanowski, K., Chlebicka, L., Stȩpiński, J., Jankowska, M., Kierdaszuk, B., Temeriusz, A., Darżynkiewicz, E., & Stolarski, R. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00116-4 · Cited by 17
Self-citationLassota, P., Stolarski, R., & Shugar, D. (1984) · Zeitschrift für Naturforschung C · doi:10.1515/znc-1984-1-210 · Cited by 13
Self-citationA new route to 2′ (3′)-O-alkyl purine nucleosides
Kuśmierek, J. T., & Shugar, D. (1978) · Nucleic Acids Research · doi:10.1093/nar/1.suppl_1.s73 · Cited by 12
Cited by
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
“Hence, so-called anti-reverse cap analogues (ARCAs; m ,3ʹ−O GpppG) were introduced 35,36 .”
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Qin, S., Tang, X., Chen, Y., Chen, K., Fan, N., Xiao, W., Zheng, Q., Li, G., Teng, Y., Wu, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01007-w · Cited by 771
Advances in the delivery of RNA therapeutics: from concept to clinical reality
Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656
“Incorporation of cap analogs such as ARCA (anti-reverse cap analogs) and poly(A) tail of 120–150 bp into in vitro transcribed (IVT) mRNAs has markedly improved expression of the encoded proteins and mRNA stability [89, 90].”
BackgroundAdvances in COVID-19 mRNA vaccine development
Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584
“To avoid this, the so‐called ARCA with only one 3’‐OH group instead of two 3’‐OH groups (ARCAs; m27,3’−OGpppG) has been introduced to prevent incorporation in the opposite orientation [43].”
Method
Metadata
- Authors
- JEMIELITY, J., FOWLER, T., ZUBEREK, J., STEPINSKI, J., LEWDOROWICZ, M., NIEDZWIECKA, A., STOLARSKI, R., DARZYNKIEWICZ, E., & RHOADS, R. E.
- Venue
- RNA
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2003-08-15
- Volume
- 9
- Issue
- 9
- Pages
- 1108-1122
- ISSN
- 1355-8382 (ISSN-L)
- 1469-9001
- OpenAlex
- W2162165801
- Cited by
- 263
- References
- 47
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.